JamesPOhrDO

PubMed

• 1 citations
  Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit.
  Marco A Mascarella, Tolani F Olonisakin, Purva Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Robert L Ferris, Moon J Fenton, Dan...> ;Clinical Cancer Research. 2023 Feb 16
• 1 citations
  A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients.
  Janielle K-A Taylor, Leila J Mady, Khalil Baddour, Uzoma K Iheagwara, Shuyan Zhai, James P Ohr, Daniel P Zandberg, Vikram C Gorantla, Robert L Ferris, Seungwon Kim, Um...> ;World Journal of Otorhinolaryngology - Head and Neck Surgery. 2022 Dec 1
• 3 citations
  Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Founda...
  Maura L Gillison, Robert L Ferris, Jonathan Harris, A Dimitrios Colevas, Loren K Mell, Christina Kong, Richard C Jordan, Kevin L Moore, Minh-Tam Truong, Claudia Kirsch...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Mar 15
• 3 citations
  A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer.
  Julie E Bauman, Zhengjia Chen, Chao Zhang, James P Ohr, Robert L Ferris, Gerald M McGorisk, Stephen Brandt, Sumathi Srivatsa, Amy Y Chen, Conor E Steuer, Dong M Shin, ...> ;Cancers. 2022 May 26
• 13 citations
  Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer.
  Robert L Ferris, Jessica Moskovitz, Sheryl Kunning, Ayana T Ruffin, Carly Reeder, James Ohr, William E Gooding, Seungwon Kim, Brian J Karlovits, Dario A A Vignali, Uma...> ;Clinical Cancer Research. 2022 Apr 1
• 25 citations
  Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis.
  Kuang, C., Park, Y., Augustin, R., Lin, Y., Hartman, D., Seigh, L., Pai, R., Sun, W., Bahary, N., Ohr, J., Rhee, J., Marks, S., Beasley, H., Shuai, Y., Herman, J., Zar...> ;Clinical Epigenetics. 2022 Jan 6
• ASO Visual Abstract: A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival.
  Richard S. Hoehn, Caroline J. Rieser, Sharon Winters, Lauren Stitt, Melissa E. Hogg, David L. Bartlett, Kenneth K. Lee, Alessandro Paniccia, James Ohr, Vikram C. Goran...> ;Annals of Surgical Oncology. 2021 May 1
• 28 citations
  Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors
  Bonnie S. Glisson, Rom Leidner, Robert L. Ferris, John D. Powderly, Naiyer A. Rizvi, Bhumsuk Keam, Reva Schneider, Sanjay Goel, James Ohr, Jennifer Burton, Yanan Zheng...> ;Clinical Cancer Research. 2020 Oct 15
• 16 citations
  Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer.
  Julie E. Bauman, James Ohr, William E. Gooding, Robert L. Ferris, Umamaheswar Duvvuri, Seungwon Kim, Jonas T. Johnson, Adam C. Soloff, Gerald J. Wallweber, John Winslo...> ;Cancers. 2020 Jun 11
• 52 citations
  Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience.
  Harish Dharmarajan, Jennifer L. Anderson, Seungwon Kim, Shaum Sridharan, Umamaheswar Duvvuri, Robert L. Ferris, Mario G. Solari, David A. Clump, Heath D. Skinner, Jame...> ;Head & Neck. 2020 Jun 1
• 3 citations
  Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer.
  Joel Thomas, Hong Wang, David A. Clump, Robert L. Ferris, Umamaheswar Duvvuri, James Ohr, Dwight E. Heron> ;Frontiers in Oncology. 2020 Feb 5
• 2 citations
  Dose-response model for severe late laryngeal toxicity after stereotactic body radiation therapy for previously-irradiated head and neck cancer.
  Diane C. Ling, John A. Vargo, Rachel J Grimm, Brian J. Gebhardt, David A. Clump, Robert L. Ferris, James Ohr, Dwight E. Heron> ;Journal of Radiosurgery and SBRT. 2020 Jan 1
• 56 citations
  Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.
  Athanassios Argiris, Shuli Li, Panayiotis Savvides, James Ohr, Jill Gilbert, Marshall A. Levine, Arnab Chakravarti, Missak Haigentz, Nabil F. Saba, Chukwuemeka Ikpeazu...> ;Journal of Clinical Oncology. 2019 Oct 16
• 102 citations
  Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.
  Marie-Nicole Theodoraki, Saigopalakrishna S. Yerneni, William E. Gooding, James Ohr, David A. Clump, Julie E. Bauman, Robert L. Ferris, Theresa L. Whiteside> ;Oncoimmunology. 2019 Apr 24
• 88 citations
  A Phase 2 Trial of Regorafenib as a Single Agent in Patients with Chemotherapy Refractory Advanced and Metastatic Biliary Tract Adenocarcinoma
  Weijing Sun, Anuj K. Patel, Daniel P. Normolle, Krishna Patel, James Ohr, James J. Lee, Nathan Bahary, Edward Chu, Natalie Streeter, Summer Drummond> ;Cancer. 2019 Mar 15
• 6 citations
  Dose-response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer.
  Diane C. Ling, John A. Vargo, Brian J. Gebhardt, Rachel J Grimm, David A. Clump, Robert L. Ferris, James Ohr, Dwight E. Heron> ;Journal of Radiosurgery and SBRT. 2019 Jan 1
• 66 citations
  Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma
  Randall E. Brand, Erkut Borazanci, Virginia Speare, Beth Dudley, Eve Karloski, Mary Linton B. Peters, Lindsey Stobie, Nathan Bahary, Herbert J. Zeh, Amer H. Zureikat, ...> ;Cancer. 2018 Sep 1
• 4 citations
  Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancer.
  Hayeon Kim, John A. Vargo, Sushil Beriwal, David A. Clump, James Ohr, Robert L. Ferris, Dwight E. Heron, M. Saiful Huq, Kenneth J. Smith> ;Head & Neck. 2018 Mar 14
• 53 citations
  Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.
  Gulidanna Shayan, Benjamin A. Kansy, Sandra P. Gibson, Raghvendra M. Srivastava, James Kyle Bryan, Julie E. Bauman, James Ohr, Seungwon Kim, Umamaheswar Duvvuri, David...> ;Clinical Cancer Research. 2018 Jan 1
• 21 citations
  Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy
  Brian J. Gebhardt, John A. Vargo, D.C. Ling, Brianna M. Jones, Mary Mohney, David A. Clump, James Ohr, Robert L. Ferris, Dwight E. Heron> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Dec 5
• 25 citations
  IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer
  Laura P. Stabile, Ann Marie Egloff, Michael K. Gibson, William E. Gooding, James Ohr, P. Zhou, Natalie J. Rothenberger, Lin Wang, Jessica L. Geiger, J. T. Flaherty, Je...> ;Oral Oncology. 2017 Jun 1
• 22 citations
  Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies.
  Brian J. Gebhardt, James Ohr, Robert L. Ferris, Umamaheswar Duvvuri, Seungwon Kim, Jonas T. Johnson, Dwight E. Heron, David A. Clump> ;American Journal of Clinical Oncology. 2017 Apr 1
• 24 citations
  Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.
  Robert L. Ferris, Jessica L. Geiger, Sumita Trivedi, Nicole C. Schmitt, Dwight E. Heron, Jonas T. Johnson, Sang Woo Kim, U. Duvvuri, D. A. Clump, Julie E. Bauman, Jame...> ;Annals of Oncology. 2016 Dec 1
• 20 citations
  Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinoma
  William Greer Albergotti, Kara S. Davis, Shira Abberbock, Julie E. Bauman, James Ohr, David A. Clump, Dwight E. Heron, Umamaheswar Duvvuri, Seungwon Kim, Jonas T. John...> ;Oral Oncology. 2016 Sep 1
• 31 citations
  Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer
  Athanassios Argiris, Julie E. Bauman, James Ohr, William E. Gooding, Dwight E. Heron, U. Duvvuri, Gregory J. Kubicek, Donna M. Posluszny, M. Vassilakopoulou, Sang Woo ...> ;Annals of Oncology. 2016 Aug 1
• Join now to see all